Atlas Trials

Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine

Clinical trial NCT00118625 · COMPLETED

Trial details

NCT number
NCT00118625
Sponsor
Allergy Therapeutics
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Type I Hypersensitivity
Start date
2005-07-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.